FDA recall record

Cequa recall — FDA D-0391-2021

Subpotent and Presence of Particulates .

Class IIIclassification
D-0391-2021official record ID
May 26, 2021report date

Recall record at a glance

Official recordD-0391-2021
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmSUN PHARMACEUTICAL INDUSTRIES Inc.
Report dateMay 26, 2021
Recall initiation dateMay 7, 2021
QuantityN/A
LocationPrinceton, NJ, United States

Official product description

Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 NDC 47335-506-96

Why the product was recalled

Subpotent and Presence of Particulates .

Distribution information

Nationwide in the US

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.